Global Adalimumab Biosimilar Market Research Report 2016

November 2016 | 118 pages | ID: G27487ED295EN
QYResearch

Abstracts

Notes:

Production, means the output of Adalimumab Biosimilar

Revenue, means the sales value of Adalimumab Biosimilar

This report studies Adalimumab Biosimilar in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• AET BioTech
• Amgen
• Boehringer Ingelheim
• Coherus Biosciences
• Fujifilm Kyowa Kirin Biologics
• LG Life Sciences/Mochida Pharmaceutical
• Momenta Pharmaceuticals
• Oncobiologics
• Pfizer
• Samsung Bioepsis
• Sandoz
• Zydus Cadila

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Adalimumab Biosimilar in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Adalimumab Biosimilar in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Adalimumab Biosimilar Market Research Report 2016

1 ADALIMUMAB BIOSIMILAR MARKET OVERVIEW

1.1 Product Overview and Scope of Adalimumab Biosimilar
1.2 Adalimumab Biosimilar Segment by Type
  1.2.1 Global Production Market Share of Adalimumab Biosimilar by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Adalimumab Biosimilar Segment by Application
  1.3.1 Adalimumab Biosimilar Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Adalimumab Biosimilar Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Adalimumab Biosimilar (2011-2021)

2 GLOBAL ADALIMUMAB BIOSIMILAR MARKET COMPETITION BY MANUFACTURERS

2.1 Global Adalimumab Biosimilar Production and Share by Manufacturers (2015 and 2016)
2.2 Global Adalimumab Biosimilar Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Adalimumab Biosimilar Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Adalimumab Biosimilar Manufacturing Base Distribution, Sales Area and Product Type
2.5 Adalimumab Biosimilar Market Competitive Situation and Trends
  2.5.1 Adalimumab Biosimilar Market Concentration Rate
  2.5.2 Adalimumab Biosimilar Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL ADALIMUMAB BIOSIMILAR PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Adalimumab Biosimilar Production and Market Share by Region (2011-2016)
3.2 Global Adalimumab Biosimilar Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL ADALIMUMAB BIOSIMILAR SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Adalimumab Biosimilar Consumption by Regions (2011-2016)
4.2 North America Adalimumab Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Adalimumab Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Adalimumab Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Adalimumab Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Adalimumab Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Adalimumab Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL ADALIMUMAB BIOSIMILAR PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Adalimumab Biosimilar Production and Market Share by Type (2011-2016)
5.2 Global Adalimumab Biosimilar Revenue and Market Share by Type (2011-2016)
5.3 Global Adalimumab Biosimilar Price by Type (2011-2016)
5.4 Global Adalimumab Biosimilar Production Growth by Type (2011-2016)

6 GLOBAL ADALIMUMAB BIOSIMILAR MARKET ANALYSIS BY APPLICATION

6.1 Global Adalimumab Biosimilar Consumption and Market Share by Application (2011-2016)
6.2 Global Adalimumab Biosimilar Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL ADALIMUMAB BIOSIMILAR MANUFACTURERS PROFILES/ANALYSIS

7.1 AET BioTech
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Adalimumab Biosimilar Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 AET BioTech Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Amgen
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Adalimumab Biosimilar Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Amgen Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Boehringer Ingelheim
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Adalimumab Biosimilar Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Boehringer Ingelheim Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Coherus Biosciences
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Adalimumab Biosimilar Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Coherus Biosciences Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Fujifilm Kyowa Kirin Biologics
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Adalimumab Biosimilar Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 LG Life Sciences/Mochida Pharmaceutical
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Adalimumab Biosimilar Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Momenta Pharmaceuticals
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Adalimumab Biosimilar Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Momenta Pharmaceuticals Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Oncobiologics
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Adalimumab Biosimilar Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Oncobiologics Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Pfizer
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Adalimumab Biosimilar Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Pfizer Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Samsung Bioepsis
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Adalimumab Biosimilar Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Samsung Bioepsis Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Sandoz
7.12 Zydus Cadila

8 ADALIMUMAB BIOSIMILAR MANUFACTURING COST ANALYSIS

8.1 Adalimumab Biosimilar Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Adalimumab Biosimilar

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Adalimumab Biosimilar Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Adalimumab Biosimilar Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL ADALIMUMAB BIOSIMILAR MARKET FORECAST (2016-2021)

12.1 Global Adalimumab Biosimilar Production, Revenue Forecast (2016-2021)
12.2 Global Adalimumab Biosimilar Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Adalimumab Biosimilar Production Forecast by Type (2016-2021)
12.4 Global Adalimumab Biosimilar Consumption Forecast by Application (2016-2021)
12.5 Adalimumab Biosimilar Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Adalimumab Biosimilar
Figure Global Production Market Share of Adalimumab Biosimilar by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Adalimumab Biosimilar Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Adalimumab Biosimilar Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Adalimumab Biosimilar Production of Key Manufacturers (2015 and 2016)
Table Global Adalimumab Biosimilar Production Share by Manufacturers (2015 and 2016)
Figure 2015 Adalimumab Biosimilar Production Share by Manufacturers
Figure 2016 Adalimumab Biosimilar Production Share by Manufacturers
Table Global Adalimumab Biosimilar Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Adalimumab Biosimilar Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Adalimumab Biosimilar Revenue Share by Manufacturers
Table 2016 Global Adalimumab Biosimilar Revenue Share by Manufacturers
Table Global Market Adalimumab Biosimilar Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Adalimumab Biosimilar Average Price of Key Manufacturers in 2015
Table Manufacturers Adalimumab Biosimilar Manufacturing Base Distribution and Sales Area
Table Manufacturers Adalimumab Biosimilar Product Type
Figure Adalimumab Biosimilar Market Share of Top 3 Manufacturers
Figure Adalimumab Biosimilar Market Share of Top 5 Manufacturers
Table Global Adalimumab Biosimilar Production by Regions (2011-2016)
Figure Global Adalimumab Biosimilar Production and Market Share by Regions (2011-2016)
Figure Global Adalimumab Biosimilar Production Market Share by Regions (2011-2016)
Figure 2015 Global Adalimumab Biosimilar Production Market Share by Regions
Table Global Adalimumab Biosimilar Revenue by Regions (2011-2016)
Table Global Adalimumab Biosimilar Revenue Market Share by Regions (2011-2016)
Table 2015 Global Adalimumab Biosimilar Revenue Market Share by Regions
Table Global Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table China Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table India Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Adalimumab Biosimilar Consumption Market by Regions (2011-2016)
Table Global Adalimumab Biosimilar Consumption Market Share by Regions (2011-2016)
Figure Global Adalimumab Biosimilar Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Adalimumab Biosimilar Consumption Market Share by Regions
Table North America Adalimumab Biosimilar Production, Consumption, Import & Export (2011-2016)
Table Europe Adalimumab Biosimilar Production, Consumption, Import & Export (2011-2016)
Table China Adalimumab Biosimilar Production, Consumption, Import & Export (2011-2016)
Table Japan Adalimumab Biosimilar Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Adalimumab Biosimilar Production, Consumption, Import & Export (2011-2016)
Table India Adalimumab Biosimilar Production, Consumption, Import & Export (2011-2016)
Table Global Adalimumab Biosimilar Production by Type (2011-2016)
Table Global Adalimumab Biosimilar Production Share by Type (2011-2016)
Figure Production Market Share of Adalimumab Biosimilar by Type (2011-2016)
Figure 2015 Production Market Share of Adalimumab Biosimilar by Type
Table Global Adalimumab Biosimilar Revenue by Type (2011-2016)
Table Global Adalimumab Biosimilar Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Adalimumab Biosimilar by Type (2011-2016)
Figure 2015 Revenue Market Share of Adalimumab Biosimilar by Type
Table Global Adalimumab Biosimilar Price by Type (2011-2016)
Figure Global Adalimumab Biosimilar Production Growth by Type (2011-2016)
Table Global Adalimumab Biosimilar Consumption by Application (2011-2016)
Table Global Adalimumab Biosimilar Consumption Market Share by Application (2011-2016)
Figure Global Adalimumab Biosimilar Consumption Market Share by Application in 2015
Table Global Adalimumab Biosimilar Consumption Growth Rate by Application (2011-2016)
Figure Global Adalimumab Biosimilar Consumption Growth Rate by Application (2011-2016)
Table AET BioTech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AET BioTech Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure AET BioTech Adalimumab Biosimilar Market Share (2011-2016)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Adalimumab Biosimilar Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim Adalimumab Biosimilar Market Share (2011-2016)
Table Coherus Biosciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Coherus Biosciences Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Coherus Biosciences Adalimumab Biosimilar Market Share (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Market Share (2011-2016)
Table LG Life Sciences/Mochida Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Market Share (2011-2016)
Table Momenta Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Momenta Pharmaceuticals Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Momenta Pharmaceuticals Adalimumab Biosimilar Market Share (2011-2016)
Table Oncobiologics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Oncobiologics Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Oncobiologics Adalimumab Biosimilar Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Adalimumab Biosimilar Market Share (2011-2016)
Table Samsung Bioepsis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Samsung Bioepsis Adalimumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Samsung Bioepsis Adalimumab Biosimilar Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Adalimumab Biosimilar
Figure Manufacturing Process Analysis of Adalimumab Biosimilar
Figure Adalimumab Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Adalimumab Biosimilar Major Manufacturers in 2015
Table Major Buyers of Adalimumab Biosimilar
Table Distributors/Traders List
Figure Global Adalimumab Biosimilar Production and Growth Rate Forecast (2016-2021)
Figure Global Adalimumab Biosimilar Revenue and Growth Rate Forecast (2016-2021)
Table Global Adalimumab Biosimilar Production Forecast by Regions (2016-2021)
Table Global Adalimumab Biosimilar Consumption Forecast by Regions (2016-2021)
Table Global Adalimumab Biosimilar Production Forecast by Type (2016-2021)
Table Global Adalimumab Biosimilar Consumption Forecast by Application (2016-2021)